TY - JOUR
T1 - Uptake and Acceptability of MyChoices
T2 - Results of a Pilot RCT of a Mobile App Designed to Increase HIV Testing and PrEP Uptake Among Young American MSM
AU - Biello, Katie B.
AU - Daddario, Salvatore R.
AU - Hill-Rorie, Jonathan
AU - Futterman, Donna
AU - Sullivan, Patrick S.
AU - Hightow-Weidman, Lisa
AU - Jones, Jeb
AU - Mimiaga, Matthew J.
AU - Mayer, Kenneth H.
N1 - Funding Information:
This study was supported by the National Institutes of Health Adolescent Trials Network (U01HD068040; principal investigators [PI]: LH and PS), Emory Center for AIDS Research (P30AI050409; PI: C del Rio) for Carekit support, and MAC AIDS Fund. The funding sources played no role in writing or influencing the decision to publish the manuscript.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/12
Y1 - 2022/12
N2 - Young men who have sex with men (YMSM) remain at disproportionate risk for HIV acquisition in the United States (US), yet use of evidence-based prevention strategies, including routine HIV testing and pre-exposure prophylaxis (PrEP), remain low. Smartphones and mobile app usage are nearly ubiquitous in this population. Given the potential for scalability, a mobile app to increase HIV testing and PrEP use among YMSM has the potential to make an extraordinary public health impact if efficacious. Based on extensive formative, community-engaged research, we developed a theory-driven mobile app—MyChoices—to increase HIV testing and PrEP uptake among YMSM. In a pilot randomized controlled trial (RCT), participants (n = 60) were randomized 2:1 to receive MyChoices or standard of care (SOC). Data from 3 to 6-month post-baseline assessments demonstrate that the app was highly acceptable (System Usability Score; mean = 75.8, SD = 10.7) and feasible (94% used the MyChoices app at least once; mean = 15.3 sessions, SD = 9.8). While not powered to assess efficacy, those in the MyChoices arm had 22% higher prevalence of HIV testing over follow-up compared to those in the SOC arm (NS). There was no difference in PrEP uptake. A fully-powered efficacy trial is warranted; if efficacy is demonstrated, the MyChoices app could be easily scaled to reach YMSM across the US.
AB - Young men who have sex with men (YMSM) remain at disproportionate risk for HIV acquisition in the United States (US), yet use of evidence-based prevention strategies, including routine HIV testing and pre-exposure prophylaxis (PrEP), remain low. Smartphones and mobile app usage are nearly ubiquitous in this population. Given the potential for scalability, a mobile app to increase HIV testing and PrEP use among YMSM has the potential to make an extraordinary public health impact if efficacious. Based on extensive formative, community-engaged research, we developed a theory-driven mobile app—MyChoices—to increase HIV testing and PrEP uptake among YMSM. In a pilot randomized controlled trial (RCT), participants (n = 60) were randomized 2:1 to receive MyChoices or standard of care (SOC). Data from 3 to 6-month post-baseline assessments demonstrate that the app was highly acceptable (System Usability Score; mean = 75.8, SD = 10.7) and feasible (94% used the MyChoices app at least once; mean = 15.3 sessions, SD = 9.8). While not powered to assess efficacy, those in the MyChoices arm had 22% higher prevalence of HIV testing over follow-up compared to those in the SOC arm (NS). There was no difference in PrEP uptake. A fully-powered efficacy trial is warranted; if efficacy is demonstrated, the MyChoices app could be easily scaled to reach YMSM across the US.
KW - HIV testing
KW - Men who have sex with men
KW - Mobile app
KW - PrEP
KW - Youth
UR - http://www.scopus.com/inward/record.url?scp=85134317148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134317148&partnerID=8YFLogxK
U2 - 10.1007/s10461-022-03724-3
DO - 10.1007/s10461-022-03724-3
M3 - Article
AN - SCOPUS:85134317148
SN - 1090-7165
VL - 26
SP - 3981
EP - 3990
JO - AIDS and Behavior
JF - AIDS and Behavior
IS - 12
ER -